20220525-dealroom.co-Healthtech_8217_s_decade_the_MENA_opportunity_38页_17mb

Healthtech's Decade Overview

Healthtech represents a significant evolution in healthcare, with tech-driven innovations aiming to improve outcomes, reduce costs, and enhance patient experiences. It is positioned as a $350 billion global market, growing at various annual growth rates across segments, driven by factors like AI integration and digital transitions.

Global Healthtech Investment

Global investment in healthtech and biotech reached record highs in 2021, with substantial venture capital funding for startups. Digital care and biopharma are key areas, with accelerations in AI and genomics. Biopharma focuses on drug discovery, while healthtech targets prevention, diagnostics, and monitoring, creating a combined enterprise value exceeding $1.9 trillion.

The MENA Region: Healthtech Opportunity

The MENA region offers a large market with 600 million people, significant healthcare expenditure, and emerging healthtech ecosystems. Investment in MENA healthtech has tripled since 2016, with digital care leading, though challenges like limited infrastructure persist. The region benefits from increasing consumer influence and government initiatives, fostering a growing startup ecosystem.

Health Players and Ecosystem Dynamics

Key stakeholders include payers (insurers, governments) seeking cost control, providers aiming for better integration, and consumers demanding user-friendly tech. Healthtech invests primarily in engagement and R&D layers, with ongoing digital integrations. Femtech and personalized therapies are rising trends, supported by local and global investor interest.

Investment Trends and Regional Insights

MENA healthtech investment shows strong growth, particularly in engagement layers. Local investors dominate (80% of funding), and dedicated funds have raised significant capital, making the region an attractive hub despite business cycle risks. Overall, healthtech presents high-reward opportunities with steady expansion.